Psychodynamic Perspectives on Personality
FDA Approved Drugs: Changes to Approved Drugs
Social Cognitive Perspective on Personality
Criticisms of the Evolutionary Perspective
The Behavioral Perspective on Personality
Group Design
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
Jacqueline Corrigan-Curay1, Amy E McKee1, Peter Stein1
1Food and Drug Administration, Silver Spring, MD jacqueline.corrigan-curay@fda.hhs.gov.
No abstract available in PubMed .